| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | myosin heavy chain binding | 8.85e-05 | 17 | 104 | 3 | GO:0032036 | |
| GeneOntologyMolecularFunction | ErbB-2 class receptor binding | 1.60e-04 | 4 | 104 | 2 | GO:0005176 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | 7.59e-06 | 93 | 104 | 6 | GO:0086003 | |
| GeneOntologyBiologicalProcess | regulation of actin filament-based process | AKAP6 CACNA1C SYNPO2 MAGEL2 MYH7B PPFIA1 CSF3 PIK3CA CTNNA3 AKAP13 CTNNA2 | 1.32e-05 | 438 | 104 | 11 | GO:0032970 |
| GeneOntologyBiologicalProcess | striated muscle cell differentiation | AKAP6 NRG1 FLNC PRICKLE1 ARID1A MYL9 CTCF VWA5A AKAP13 HDAC1 | 2.86e-05 | 391 | 104 | 10 | GO:0051146 |
| GeneOntologyBiologicalProcess | cardiac muscle cell differentiation | 3.21e-05 | 177 | 104 | 7 | GO:0055007 | |
| GeneOntologyBiologicalProcess | muscle contraction | AKAP6 CACNA1C TSHZ3 MYH7B SULF2 MYL9 NUP155 PIK3CA CTNNA3 PRKCA | 3.47e-05 | 400 | 104 | 10 | GO:0006936 |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 4.49e-05 | 127 | 104 | 6 | GO:0070252 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle cell contraction | 6.47e-05 | 43 | 104 | 4 | GO:0086004 | |
| GeneOntologyBiologicalProcess | muscle cell differentiation | AKAP6 NRG1 FLNC TSHZ3 PRICKLE1 ARID1A MYL9 CTCF VWA5A AKAP13 HDAC1 | 7.64e-05 | 531 | 104 | 11 | GO:0042692 |
| GeneOntologyBiologicalProcess | muscle system process | AKAP6 CACNA1C TSHZ3 MYH7B SULF2 MYL9 NUP155 PIK3CA CTNNA3 PRKCA AKAP13 | 9.94e-05 | 547 | 104 | 11 | GO:0003012 |
| GeneOntologyBiologicalProcess | actin filament-based movement | 1.26e-04 | 153 | 104 | 6 | GO:0030048 | |
| GeneOntologyBiologicalProcess | cardiocyte differentiation | 1.30e-04 | 221 | 104 | 7 | GO:0035051 | |
| GeneOntologyBiologicalProcess | regulation of actin filament-based movement | 1.48e-04 | 53 | 104 | 4 | GO:1903115 | |
| GeneOntologyBiologicalProcess | cellular glucuronidation | 1.55e-04 | 21 | 104 | 3 | GO:0052695 | |
| GeneOntologyBiologicalProcess | ERBB signaling pathway | 1.61e-04 | 160 | 104 | 6 | GO:0038127 | |
| GeneOntologyBiologicalProcess | heart process | 1.72e-04 | 309 | 104 | 8 | GO:0003015 | |
| GeneOntologyBiologicalProcess | actin filament-based process | AKAP6 CACNA1C FLNC SYNPO2 MAGEL2 MYH7B PPFIA1 MYL9 NUP155 CSF3 PIK3CA CTNNA3 AKAP13 CTNNA2 | 1.94e-04 | 912 | 104 | 14 | GO:0030029 |
| GeneOntologyBiologicalProcess | cardiac muscle contraction | 2.03e-04 | 167 | 104 | 6 | GO:0060048 | |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | 2.98e-04 | 26 | 104 | 3 | GO:0019585 | |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | 2.98e-04 | 26 | 104 | 3 | GO:0006063 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | NRG1 PRTG PCDHGC4 PRICKLE1 NEXMIF ARID1A MYL12A ARID1B MYL9 PIK3CA CTNNA3 PRKCA LRRC7 CTNNA2 CDHR4 | 3.22e-04 | 1077 | 104 | 15 | GO:0098609 |
| GeneOntologyBiologicalProcess | muscle structure development | AKAP6 NRG1 FLNC TSHZ3 PRICKLE1 CHKB ARID1A ARID1B MYL9 CTCF VWA5A AKAP13 HDAC1 | 3.78e-04 | 858 | 104 | 13 | GO:0061061 |
| GeneOntologyBiologicalProcess | calcium-mediated signaling | 4.02e-04 | 266 | 104 | 7 | GO:0019722 | |
| GeneOntologyCellularComponent | Z disc | 9.91e-06 | 151 | 103 | 7 | GO:0030018 | |
| GeneOntologyCellularComponent | myosin II complex | 1.04e-05 | 28 | 103 | 4 | GO:0016460 | |
| GeneOntologyCellularComponent | I band | 1.83e-05 | 166 | 103 | 7 | GO:0031674 | |
| GeneOntologyCellularComponent | myofibril | 6.22e-05 | 273 | 103 | 8 | GO:0030016 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 9.48e-05 | 290 | 103 | 8 | GO:0043292 | |
| GeneOntologyCellularComponent | actin cytoskeleton | FLNC SYNPO2 MYH7B ACTR10 DAPK1 MYL12A MYL9 AKAP13 LRRC7 CTNNA2 MYL12B | 1.28e-04 | 576 | 103 | 11 | GO:0015629 |
| GeneOntologyCellularComponent | myosin complex | 2.05e-04 | 59 | 103 | 4 | GO:0016459 | |
| GeneOntologyCellularComponent | sarcomere | 2.35e-04 | 249 | 103 | 7 | GO:0030017 | |
| GeneOntologyCellularComponent | intercalated disc | 3.55e-04 | 68 | 103 | 4 | GO:0014704 | |
| GeneOntologyCellularComponent | ooplasm | 3.56e-04 | 6 | 103 | 2 | GO:1990917 | |
| GeneOntologyCellularComponent | axon | CACNA1C NRG1 PRTG TSHZ3 FZD3 ACTR10 PPFIA1 PPP1R2 HPCA PPP1R2B PRKCA LRRC7 CTNNA2 | 4.33e-04 | 891 | 103 | 13 | GO:0030424 |
| GeneOntologyCellularComponent | anchoring junction | AKAP6 FLNC SYNPO2 PPFIA1 ERBIN PRX PIKFYVE PIK3CA CTNNA3 PRKCA LRRC7 TNS4 CTNNA2 | 1.01e-03 | 976 | 103 | 13 | GO:0070161 |
| GeneOntologyCellularComponent | bBAF complex | 1.05e-03 | 10 | 103 | 2 | GO:0140092 | |
| GeneOntologyCellularComponent | cell-cell contact zone | 1.21e-03 | 94 | 103 | 4 | GO:0044291 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 1.30e-03 | 96 | 103 | 4 | GO:0070603 | |
| GeneOntologyCellularComponent | contractile actin filament bundle | 1.94e-03 | 107 | 103 | 4 | GO:0097517 | |
| GeneOntologyCellularComponent | stress fiber | 1.94e-03 | 107 | 103 | 4 | GO:0001725 | |
| GeneOntologyCellularComponent | npBAF complex | 2.11e-03 | 14 | 103 | 2 | GO:0071564 | |
| GeneOntologyCellularComponent | brahma complex | 2.11e-03 | 14 | 103 | 2 | GO:0035060 | |
| GeneOntologyCellularComponent | actomyosin | 2.69e-03 | 117 | 103 | 4 | GO:0042641 | |
| GeneOntologyCellularComponent | nBAF complex | 2.76e-03 | 16 | 103 | 2 | GO:0071565 | |
| GeneOntologyCellularComponent | actin filament bundle | 2.78e-03 | 118 | 103 | 4 | GO:0032432 | |
| MousePheno | abnormal cardiac muscle tissue morphology | CACNA1C NRG1 ERG PRICKLE1 KLF3 MECOM ARID1A PIKFYVE CTCF ASXL3 CTNNA3 PRKCA AKAP13 PRKAG2 | 8.46e-07 | 489 | 82 | 14 | MP:0010630 |
| MousePheno | abnormal heart layer morphology | CACNA1C NRG1 PRICKLE1 KLF3 MECOM ARID1A PIKFYVE CTCF PIK3CA ASXL3 CTNNA3 PRKCA AKAP13 | 9.66e-07 | 422 | 82 | 13 | MP:0010545 |
| MousePheno | abnormal muscle morphology | CACNA1C KDM3A NRG1 FLNC MAGEL2 ERG ACADS PRICKLE1 KLF3 MECOM CHKB ARID1A PIKFYVE CTCF PIK3CA ASXL3 CTNNA3 PRKCA AKAP13 PRKAG2 | 4.23e-06 | 1106 | 82 | 20 | MP:0002108 |
| MousePheno | abnormal myocardium layer morphology | CACNA1C NRG1 PRICKLE1 KLF3 MECOM ARID1A PIKFYVE CTCF ASXL3 CTNNA3 PRKCA AKAP13 | 4.94e-06 | 414 | 82 | 12 | MP:0005329 |
| MousePheno | perinatal lethality | AKAP6 CACNA1C NRG1 FLNC TSHZ3 MAGEL2 FZD3 POT1 KAT6A KLF3 MECOM ARID1A PIKFYVE ARID1B SULF2 PNPLA1 CTCF PIK3CA CTNNA2 DYRK2 | 5.85e-06 | 1130 | 82 | 20 | MP:0002081 |
| MousePheno | increased heart right atrium size | 2.27e-05 | 10 | 82 | 3 | MP:0008727 | |
| MousePheno | neonatal lethality | AKAP6 CACNA1C NRG1 FLNC TSHZ3 FZD3 POT1 KAT6A KLF3 ARID1A SULF2 PNPLA1 CTCF PIK3CA CTNNA2 | 5.46e-05 | 799 | 82 | 15 | MP:0002058 |
| MousePheno | perinatal lethality, complete penetrance | CACNA1C NRG1 FLNC TSHZ3 FZD3 POT1 KAT6A MECOM ARID1A ARID1B SULF2 PNPLA1 CTCF DYRK2 | 6.10e-05 | 712 | 82 | 14 | MP:0011089 |
| MousePheno | enlarged lateral ventricles | 1.32e-04 | 84 | 82 | 5 | MP:0008535 | |
| MousePheno | abnormal heart right atrium morphology | 1.36e-04 | 45 | 82 | 4 | MP:0003922 | |
| MousePheno | hyporesponsive to tactile stimuli | 1.36e-04 | 45 | 82 | 4 | MP:0005498 | |
| MousePheno | abnormal dentate gyrus subgranular zone morphology | 2.02e-04 | 4 | 82 | 2 | MP:0030981 | |
| MousePheno | neonatal lethality, complete penetrance | CACNA1C NRG1 FLNC TSHZ3 FZD3 POT1 KAT6A ARID1A SULF2 PNPLA1 CTCF | 2.73e-04 | 534 | 82 | 11 | MP:0011087 |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | CACNA1C NRG1 FLNC TSHZ3 PRICKLE1 FZD3 POT1 KAT6A KLF3 MECOM ARID1A PIKFYVE ARID1B SULF2 PNPLA1 MYL9 CTCF DYRK2 | 3.29e-04 | 1269 | 82 | 18 | MP:0011111 |
| MousePheno | abnormal cardiac muscle contractility | 3.85e-04 | 302 | 82 | 8 | MP:0002972 | |
| Domain | EF-hand_1 | 1.99e-05 | 152 | 102 | 7 | PF00036 | |
| Domain | EFh | 2.56e-05 | 158 | 102 | 7 | SM00054 | |
| Domain | EF-hand-dom_pair | 2.77e-05 | 287 | 102 | 9 | IPR011992 | |
| Domain | BAF250_C | 2.95e-05 | 2 | 102 | 2 | IPR033388 | |
| Domain | BAF250_C | 2.95e-05 | 2 | 102 | 2 | PF12031 | |
| Domain | BAF250/Osa | 2.95e-05 | 2 | 102 | 2 | IPR021906 | |
| Domain | Recoverin | 4.35e-05 | 13 | 102 | 3 | IPR028846 | |
| Domain | EF_Hand_1_Ca_BS | 4.91e-05 | 175 | 102 | 7 | IPR018247 | |
| Domain | EF_hand_DJBP | 8.83e-05 | 3 | 102 | 2 | IPR015070 | |
| Domain | EF-hand_11 | 8.83e-05 | 3 | 102 | 2 | PF08976 | |
| Domain | - | 9.23e-05 | 261 | 102 | 8 | 1.10.238.10 | |
| Domain | EF-hand_7 | 1.02e-04 | 85 | 102 | 5 | PF13499 | |
| Domain | PDZ | 1.24e-04 | 141 | 102 | 6 | PF00595 | |
| Domain | EF_HAND_1 | 1.29e-04 | 204 | 102 | 7 | PS00018 | |
| Domain | PDZ | 1.61e-04 | 148 | 102 | 6 | SM00228 | |
| Domain | - | 1.73e-04 | 150 | 102 | 6 | 2.30.42.10 | |
| Domain | VINCULIN_1 | 1.76e-04 | 4 | 102 | 2 | PS00663 | |
| Domain | Vinculin_CS | 1.76e-04 | 4 | 102 | 2 | IPR000633 | |
| Domain | Alpha_catenin | 1.76e-04 | 4 | 102 | 2 | IPR001033 | |
| Domain | PDZ | 1.80e-04 | 151 | 102 | 6 | PS50106 | |
| Domain | PDZ | 1.86e-04 | 152 | 102 | 6 | IPR001478 | |
| Domain | UDPGT | 1.96e-04 | 21 | 102 | 3 | PF00201 | |
| Domain | UDPGT | 1.96e-04 | 21 | 102 | 3 | PS00375 | |
| Domain | UDP_glucos_trans | 1.96e-04 | 21 | 102 | 3 | IPR002213 | |
| Domain | EF_HAND_2 | 2.76e-04 | 231 | 102 | 7 | PS50222 | |
| Domain | EF_hand_dom | 2.83e-04 | 232 | 102 | 7 | IPR002048 | |
| Domain | Vinculin | 2.92e-04 | 5 | 102 | 2 | PF01044 | |
| Domain | Vinculin/catenin | 6.09e-04 | 7 | 102 | 2 | IPR006077 | |
| Domain | EF-hand_8 | 8.37e-04 | 34 | 102 | 3 | PF13833 | |
| Domain | EF-hand_6 | 2.22e-03 | 13 | 102 | 2 | PF13405 | |
| Domain | - | 2.96e-03 | 15 | 102 | 2 | 1.10.150.60 | |
| Domain | BRIGHT | 2.96e-03 | 15 | 102 | 2 | SM00501 | |
| Domain | ARID_dom | 2.96e-03 | 15 | 102 | 2 | IPR001606 | |
| Domain | ARID | 2.96e-03 | 15 | 102 | 2 | PS51011 | |
| Domain | ARID | 2.96e-03 | 15 | 102 | 2 | PF01388 | |
| Domain | ZF_DAG_PE_1 | 5.18e-03 | 64 | 102 | 3 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 5.18e-03 | 64 | 102 | 3 | PS50081 | |
| Domain | C1 | 5.41e-03 | 65 | 102 | 3 | SM00109 | |
| Domain | PE/DAG-bd | 5.64e-03 | 66 | 102 | 3 | IPR002219 | |
| Pathway | KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION | 3.47e-06 | 116 | 78 | 7 | M2164 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB2 | 7.94e-06 | 50 | 78 | 5 | M553 | |
| Pathway | KEGG_TIGHT_JUNCTION | 8.18e-06 | 132 | 78 | 7 | M11355 | |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | 1.61e-05 | 28 | 78 | 4 | M19580 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_SOPB_TO_RHOA_SIGNALING_PATHWAY | 1.90e-05 | 10 | 78 | 3 | M47739 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPAA_TO_ITGA_B_RHOGEF_RHOA_SIGNALING_PATHWAY | 2.60e-05 | 11 | 78 | 3 | M47721 | |
| Pathway | REACTOME_ATORVASTATIN_ADME | 7.07e-05 | 15 | 78 | 3 | MM15697 | |
| Pathway | REACTOME_HEME_DEGRADATION | 1.74e-04 | 20 | 78 | 3 | MM14721 | |
| Pathway | REACTOME_PREDNISONE_ADME | 2.66e-04 | 23 | 78 | 3 | MM16639 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PAKS | 2.66e-04 | 23 | 78 | 3 | MM15222 | |
| Pathway | REACTOME_GLUCURONIDATION | 3.03e-04 | 24 | 78 | 3 | MM14599 | |
| Pathway | REACTOME_GLUCURONIDATION | 3.43e-04 | 25 | 78 | 3 | M17787 | |
| Pathway | WP_GLUCURONIDATION | 3.43e-04 | 25 | 78 | 3 | MM15820 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 3.43e-04 | 25 | 78 | 3 | M605 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB2_IN_CANCER | 3.87e-04 | 26 | 78 | 3 | M29535 | |
| Pathway | WP_GLUCURONIDATION | 3.87e-04 | 26 | 78 | 3 | M39404 | |
| Pathway | KEGG_PATHWAYS_IN_CANCER | 4.22e-04 | 325 | 78 | 8 | M12868 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 4.55e-04 | 65 | 78 | 4 | M39682 | |
| Pathway | REACTOME_DOWNREGULATION_OF_ERBB2_SIGNALING | 5.37e-04 | 29 | 78 | 3 | M27756 | |
| Pubmed | 2.67e-08 | 3 | 105 | 3 | 11942626 | ||
| Pubmed | Mouse myosin-19 is a plus-end-directed, high-duty ratio molecular motor. | 1.07e-07 | 4 | 105 | 3 | 24825904 | |
| Pubmed | NCALD NYAP2 ACADS DGKG ERBIN YARS1 PPP1R2 MYL12A HPCA PPP1R2B HPCAL1 PRKCA LRRC7 CTNNA2 MYL12B ALDH6A1 | 3.21e-07 | 1139 | 105 | 16 | 36417873 | |
| Pubmed | Genetic determinants influencing human serum metabolome among African Americans. | 7.96e-07 | 24 | 105 | 4 | 24625756 | |
| Pubmed | 9.28e-07 | 7 | 105 | 3 | 21126233 | ||
| Pubmed | 9.28e-07 | 7 | 105 | 3 | 8207020 | ||
| Pubmed | FLNC PPFIA1 DAPK1 ARID1A ERBIN YARS1 CUL5 DHX15 MYL12A HPCA ATP8A1 NCAN PRKCA LRRC7 CTNNA2 PRKAG2 MYL12B | 1.34e-06 | 1431 | 105 | 17 | 37142655 | |
| Pubmed | 1.48e-06 | 8 | 105 | 3 | 33424621 | ||
| Pubmed | CACNA1C FLNC NCALD PCDHGC4 MYH7B DTNB PPFIA1 CC2D1B ARID1A ERBIN PRX HPCA ZC3H7A MIA2 HPCAL1 CTAGE1 HDAC1 | 1.49e-06 | 1442 | 105 | 17 | 35575683 | |
| Pubmed | 2.22e-06 | 9 | 105 | 3 | 22511988 | ||
| Pubmed | 2.22e-06 | 9 | 105 | 3 | 1339448 | ||
| Pubmed | 3.16e-06 | 10 | 105 | 3 | 23642732 | ||
| Pubmed | 3.16e-06 | 10 | 105 | 3 | 11465080 | ||
| Pubmed | 3.16e-06 | 10 | 105 | 3 | 11964161 | ||
| Pubmed | 3.16e-06 | 10 | 105 | 3 | 23371916 | ||
| Pubmed | A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia. | 3.16e-06 | 10 | 105 | 3 | 22558097 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | NCALD DTNB PRX PPP1R2 HPCA PPP1R2B MYL9 HPCAL1 PRKCA PRKAG2 MYL12B HDAC1 DYRK2 | 3.76e-06 | 910 | 105 | 13 | 36736316 |
| Pubmed | 4.33e-06 | 11 | 105 | 3 | 14657280 | ||
| Pubmed | 4.33e-06 | 11 | 105 | 3 | 9171826 | ||
| Pubmed | 5.77e-06 | 12 | 105 | 3 | 19419973 | ||
| Pubmed | Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. | 5.77e-06 | 12 | 105 | 3 | 11434514 | |
| Pubmed | UGT1A1 is a major locus influencing bilirubin levels in African Americans. | 7.48e-06 | 13 | 105 | 3 | 22085899 | |
| Pubmed | Genome-wide analysis of hepatic lipid content in extreme obesity. | 7.48e-06 | 13 | 105 | 3 | 25246029 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 30851247 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 8068691 | ||
| Pubmed | Identification and characterization of two distinct PPP1R2 isoforms in human spermatozoa. | 9.03e-06 | 2 | 105 | 2 | 23506001 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 28692045 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 20189675 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 24002784 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 24641623 | ||
| Pubmed | Phosphorylation of farnesoid X receptor by protein kinase C promotes its transcriptional activity. | 9.03e-06 | 2 | 105 | 2 | 18755856 | |
| Pubmed | Dissecting the role of SWI/SNF component ARID1B in steady-state hematopoiesis. | 9.03e-06 | 2 | 105 | 2 | 37611161 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 32791957 | ||
| Pubmed | Chromatin accessibility underlies synthetic lethality of SWI/SNF subunits in ARID1A-mutant cancers. | 9.03e-06 | 2 | 105 | 2 | 28967863 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 26823757 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 24100690 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 34386776 | ||
| Pubmed | Neurocalcin family: a novel calcium-binding protein abundant in bovine central nervous system. | 9.03e-06 | 2 | 105 | 2 | 8387172 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 23202128 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 33890484 | ||
| Pubmed | Expression and significance of EBV, ARID1A and PIK3CA in gastric carcinoma. | 9.03e-06 | 2 | 105 | 2 | 30747208 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 11552981 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 23144896 | ||
| Pubmed | ARID1B is a specific vulnerability in ARID1A-mutant cancers. | 9.03e-06 | 2 | 105 | 2 | 24562383 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 22157930 | ||
| Pubmed | ARID1B as a Potential Therapeutic Target for ARID1A-Mutant Ovarian Clear Cell Carcinoma. | 9.03e-06 | 2 | 105 | 2 | 29890703 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 24788099 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 33052929 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 38017109 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 19458253 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 28363979 | ||
| Pubmed | Concurrent ARID1A and ARID1B inactivation in endometrial and ovarian dedifferentiated carcinomas. | 9.03e-06 | 2 | 105 | 2 | 27562491 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 14570768 | ||
| Pubmed | 9.50e-06 | 14 | 105 | 3 | 21646302 | ||
| Pubmed | Human UDP-glucuronosyltransferases: metabolism, expression, and disease. | 9.50e-06 | 14 | 105 | 3 | 10836148 | |
| Pubmed | 9.50e-06 | 14 | 105 | 3 | 9295054 | ||
| Pubmed | Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation. | 9.50e-06 | 14 | 105 | 3 | 14672974 | |
| Pubmed | Distinct mammalian SWI/SNF chromatin remodeling complexes with opposing roles in cell-cycle control. | 1.18e-05 | 15 | 105 | 3 | 17255939 | |
| Pubmed | 1.43e-05 | 101 | 105 | 5 | 18519826 | ||
| Pubmed | GATA4 transcription factor is required for ventral morphogenesis and heart tube formation. | 1.46e-05 | 16 | 105 | 3 | 9136932 | |
| Pubmed | Genome-wide association meta-analysis for total serum bilirubin levels. | 1.46e-05 | 16 | 105 | 3 | 19414484 | |
| Pubmed | 1.46e-05 | 16 | 105 | 3 | 19794400 | ||
| Pubmed | Genome-wide association of serum bilirubin levels in Korean population. | 1.76e-05 | 17 | 105 | 3 | 20639394 | |
| Pubmed | A genome-wide assessment of variability in human serum metabolism. | 2.50e-05 | 19 | 105 | 3 | 23281178 | |
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 21647563 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 11836243 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 23702729 | ||
| Pubmed | AATF/Che-1 acts as a phosphorylation-dependent molecular modulator to repress p53-driven apoptosis. | 2.70e-05 | 3 | 105 | 2 | 22909821 | |
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 12051676 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 24195737 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 21940993 | ||
| Pubmed | Structural basis for regulation of protein phosphatase 1 by inhibitor-2. | 2.70e-05 | 3 | 105 | 2 | 17636256 | |
| Pubmed | The leukemic oncogene EVI1 hijacks a MYC super-enhancer by CTCF-facilitated loops. | 2.70e-05 | 3 | 105 | 2 | 34584081 | |
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 31391455 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 24252174 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 21383159 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 34512623 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 33432679 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 12704190 | ||
| Pubmed | Leucine zipper domain of HIV-1 gp41 interacted specifically with alpha-catenin. | 2.70e-05 | 3 | 105 | 2 | 11883950 | |
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 27681437 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 12754211 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 34044070 | ||
| Pubmed | Genome-Wide Transcriptional Regulation Mediated by Biochemically Distinct SWI/SNF Complexes. | 2.70e-05 | 3 | 105 | 2 | 26716708 | |
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 34697060 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 26945423 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 30627910 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 36269819 | ||
| Pubmed | Mutations affecting components of the SWI/SNF complex cause Coffin-Siris syndrome. | 2.70e-05 | 3 | 105 | 2 | 22426308 | |
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 31913353 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 24382590 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 34036385 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 23611809 | ||
| Pubmed | The cytoplasmic domain of HIV-1 gp41 interacts with the carboxyl-terminal region of alpha-catenin. | 2.70e-05 | 3 | 105 | 2 | 10420987 | |
| Pubmed | Human metabolic individuality in biomedical and pharmaceutical research. | 2.74e-05 | 57 | 105 | 4 | 21886157 | |
| Pubmed | 2.94e-05 | 20 | 105 | 3 | 34220450 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | FLNC C9orf78 ACTR10 PPFIA1 CC2D1B FAF1 YARS1 PPP1R2 CUL5 DHX15 MYL12A MYL9 NUP155 HDAC1 AHNAK2 | 3.17e-05 | 1455 | 105 | 15 | 22863883 |
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 3.71e-05 | 123 | 105 | 5 | 26912792 | |
| Pubmed | Genetic variations and haplotypes of UDP-glucuronosyltransferase 1A locus in a Korean population. | 5.40e-05 | 4 | 105 | 2 | 18223459 | |
| Pubmed | 5.40e-05 | 4 | 105 | 2 | 25625625 | ||
| Interaction | CREM interactions | 4.18e-07 | 90 | 104 | 7 | int:CREM | |
| Interaction | DDX5 interactions | NYAP2 ERG KAT6A DAPK1 RAB11FIP1 FAF1 CUL5 DHX15 CTCF PIK3CA PRKCA HDAC1 DYRK2 | 7.24e-06 | 568 | 104 | 13 | int:DDX5 |
| Cytoband | 5q12.3 | 9.25e-06 | 18 | 105 | 3 | 5q12.3 | |
| Cytoband | 2q37 | 4.99e-05 | 31 | 105 | 3 | 2q37 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q12 | 4.79e-04 | 66 | 105 | 3 | chr5q12 | |
| Cytoband | 18p11.31 | 2.02e-03 | 29 | 105 | 2 | 18p11.31 | |
| Cytoband | 12q23.1 | 2.61e-03 | 33 | 105 | 2 | 12q23.1 | |
| GeneFamily | Myosin light chains|EF-hand domain containing | 2.61e-05 | 14 | 77 | 3 | 657 | |
| GeneFamily | EF-hand domain containing | 4.07e-05 | 219 | 77 | 7 | 863 | |
| GeneFamily | PDZ domain containing | 4.64e-05 | 152 | 77 | 6 | 1220 | |
| GeneFamily | UDP glucuronosyltransferases | 3.37e-04 | 32 | 77 | 3 | 363 | |
| GeneFamily | AT-rich interaction domain containing | 1.81e-03 | 15 | 77 | 2 | 418 | |
| GeneFamily | CTAGE family | 1.81e-03 | 15 | 77 | 2 | 907 | |
| Coexpression | LAKE_ADULT_KIDNEY_C27_VASCULAR_SMOOTH_MUSCLE_CELLS_AND_PERICYTES | 2.90e-06 | 155 | 104 | 7 | M39246 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | KDM3A NRG1 PPFIA1 KAT6A MECOM DAPK1 TIPRL DHX15 PIKFYVE MIA2 CTCF HPCAL1 PRKCA AKAP13 | 7.37e-06 | 856 | 104 | 14 | M4500 |
| Coexpression | GSE18893_TCONV_VS_TREG_2H_TNF_STIM_DN | 1.27e-05 | 194 | 104 | 7 | M7306 | |
| Coexpression | GSE22886_IGG_IGA_MEMORY_BCELL_VS_BM_PLASMA_CELL_UP | 1.54e-05 | 200 | 104 | 7 | M4449 | |
| Coexpression | EPPERT_CE_HSC_LSC | 2.12e-05 | 41 | 104 | 4 | M19233 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | AKAP6 CACNA1C FLNC SYNPO2 MYH7B DGKG MYL12A MAST4 CTNNA3 AKAP13 | 2.11e-11 | 184 | 105 | 10 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | AKAP6 FNIP2 CACNA1C FLNC MYH7B DGKG MAST4 CTNNA3 AKAP13 PRKAG2 | 2.75e-11 | 189 | 105 | 10 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 7.48e-10 | 190 | 105 | 9 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.39e-08 | 185 | 105 | 8 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 1.65e-08 | 189 | 105 | 8 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.65e-08 | 189 | 105 | 8 | da9ecc0d7b81c1901f30f97bb44112dc85444a66 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 1.71e-08 | 190 | 105 | 8 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 1.71e-08 | 190 | 105 | 8 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 1.79e-08 | 191 | 105 | 8 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.62e-07 | 170 | 105 | 7 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.48e-07 | 181 | 105 | 7 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 2.57e-07 | 182 | 105 | 7 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | COVID-19-Heart-CM_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.77e-07 | 184 | 105 | 7 | e737f0f14c49b07bbb04a165083ac32210bc5690 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.87e-07 | 185 | 105 | 7 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.20e-07 | 188 | 105 | 7 | 74f7d216209cabdc96b2d46685b0ae017fdcc8fc | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 3.57e-07 | 191 | 105 | 7 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.83e-07 | 193 | 105 | 7 | 5578f7cb3ec68c9a38cc5304b618b81283024d5e | |
| ToppCell | Fetal_29-31_weeks-Epithelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.83e-07 | 193 | 105 | 7 | a0ca3231992f14abcf1a6129573bace320e89d2a | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 3.96e-07 | 194 | 105 | 7 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 3.96e-07 | 194 | 105 | 7 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 4.10e-07 | 195 | 105 | 7 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.39e-07 | 197 | 105 | 7 | bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.54e-07 | 198 | 105 | 7 | bd42c03e384e64f61b02618cf1a5440033bb04b2 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.54e-07 | 198 | 105 | 7 | c12e7511628db819a52959bb68580e27c00c2e41 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.70e-07 | 199 | 105 | 7 | b768496381362f9a2706e0892b5a7a0db82e09ce | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.70e-07 | 199 | 105 | 7 | b1753474152b82a0b811b9878c890a359e14919a | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.86e-07 | 200 | 105 | 7 | a66449b22b39dd6987fc2c3ed160d24564234ced | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.22e-06 | 160 | 105 | 6 | fd14dfeb7021a4b7299371854dc8fc1fd66c8dae | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D231|Adult / Lineage, Cell type, age group and donor | 3.15e-06 | 170 | 105 | 6 | 269dee5abca9f6aa079f116f0d8f1d198604d9d4 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 3.37e-06 | 172 | 105 | 6 | c62cad0f4212d1e9ea1ec3143ad3c4e06aff0ebf | |
| ToppCell | COVID-19-Heart-VSMC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.72e-06 | 175 | 105 | 6 | 1125f0d3a5b2388fa77a820dea0288e824d84a82 | |
| ToppCell | LV|World / Chamber and Cluster_Paper | 4.37e-06 | 180 | 105 | 6 | 5ac6f485a58bb29462fec02dfbe8eb70864eafe3 | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 4.37e-06 | 180 | 105 | 6 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.81e-06 | 183 | 105 | 6 | e84539978ab4de42e19186aed00f24bb50cbc21f | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-ACTC+_SMC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.96e-06 | 184 | 105 | 6 | 39168ca2bbf1369c9fe87c67f0aaff5e3cd03151 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.12e-06 | 185 | 105 | 6 | d602a9b35e86e6f2a14a58e40fc4fb97f5fa3b08 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_RPL31P31|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.12e-06 | 185 | 105 | 6 | a1b2525da018abe458908cab7268bd403ee98d92 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.28e-06 | 186 | 105 | 6 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.28e-06 | 186 | 105 | 6 | a95744b8649096bd7cfc3591a02841fa411085b3 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.44e-06 | 187 | 105 | 6 | 3912bbb610a4a84791e9bda92a2d57a52c31d29e | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 5.61e-06 | 188 | 105 | 6 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.78e-06 | 189 | 105 | 6 | 7fbe855bfdb47d35e040b04a80fe4b729a3764e8 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.78e-06 | 189 | 105 | 6 | b6d5dec55bf352f6ae19d8f488ae70aa10fb9a8f | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.78e-06 | 189 | 105 | 6 | 975e7aa3b862a8b07c2ab8426a14f5cc54998aca | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.78e-06 | 189 | 105 | 6 | 06b35abecd29f902cf251fcc1f6ad33db7ab08a2 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.78e-06 | 189 | 105 | 6 | 127ad2ba3e794df8cce2eee3e4171bccb5aad51b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.78e-06 | 189 | 105 | 6 | 2cfb4d12f75678d1619f4743838a0e954bd57761 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.96e-06 | 190 | 105 | 6 | e102622f05c7f3e1bd8b224ea159d57033793ee0 | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.96e-06 | 190 | 105 | 6 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.96e-06 | 190 | 105 | 6 | 73d94fbae92029745989a8712eed8b99fd84c193 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.96e-06 | 190 | 105 | 6 | 1ab3f19f1ce9f58e5125135704d94655a2e330a0 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.14e-06 | 191 | 105 | 6 | 8e8beb8e8a3b33cac83d3f7ce915a71e3654fdab | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.14e-06 | 191 | 105 | 6 | de2cd94ee88a7754f86d39469e38374d668210c7 | |
| ToppCell | COVID-19-kidney-vSMC/Pericyte|kidney / Disease (COVID-19 only), tissue and cell type | 6.14e-06 | 191 | 105 | 6 | fad8eaa536001b911d05ae2b12150c2398cc6f88 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.14e-06 | 191 | 105 | 6 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.14e-06 | 191 | 105 | 6 | 60bc1f3efa7bbad5cb7944fe5e049ea79cd1745a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.33e-06 | 192 | 105 | 6 | bfab13793e54de2550ee171397f7ece0625cdb4a | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.33e-06 | 192 | 105 | 6 | cc9911e182a289779a2612bc213daae5607689e7 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.33e-06 | 192 | 105 | 6 | b54b0d5b88139905521c8d5d58332e89c08d589c | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.52e-06 | 193 | 105 | 6 | 4aa976b596830b585e8d9c808d5072ed23d13a7c | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.52e-06 | 193 | 105 | 6 | 173f1d83133f5ffa88e2a75d28835ad7acd2aa90 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 6.52e-06 | 193 | 105 | 6 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.72e-06 | 194 | 105 | 6 | 5c3b2b05d1e4f146551fe4c920263d8e6ca34de3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.72e-06 | 194 | 105 | 6 | ab9cad697f9209d2889bc02b43b502dfeb2ebfef | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.92e-06 | 195 | 105 | 6 | 787e95fb59c40bba784544b662fac37606ae1427 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M|organoid_Kanton_Nature / Sample Type, Dataset, Time_group, and Cell type. | 7.12e-06 | 196 | 105 | 6 | 1e9ccbd5be7839a74108f0cd07a6d2d736bc7f1b | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-K_(Pericytes)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 7.12e-06 | 196 | 105 | 6 | 541b1fcf509e362f6f48720046cb5378aaf7c591 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.12e-06 | 196 | 105 | 6 | 9830fb3da7a60f65ad463e9054bb77c06b025e4d | |
| ToppCell | COVID-19-Heart-Mito_CM|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.33e-06 | 197 | 105 | 6 | 44e49943d62bfe622b40ad0460093d31540544df | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblast-(8)_Smooth_muscle_cells|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.33e-06 | 197 | 105 | 6 | 4e0c3ea4f4a04a41532806edf3bccf7845c86fa5 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.55e-06 | 198 | 105 | 6 | 7dd874b09c81cc512ccc1e9b65f290a5f94d736e | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.55e-06 | 198 | 105 | 6 | f948391296c261c473d339069a6d0f20ccd6f38f | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.55e-06 | 198 | 105 | 6 | 2e2a4e1756bba6f4fbe529559a97d2993c890b4b | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.55e-06 | 198 | 105 | 6 | 22e766df1276c5b14aa0d83f434f47140ebb98ea | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Diffuse-7|TCGA-Stomach / Sample_Type by Project: Shred V9 | 1.71e-05 | 135 | 105 | 5 | 451e90c154e26ae4f72269d6765e7ef51d67313a | |
| ToppCell | Pericytes-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 2.84e-05 | 150 | 105 | 5 | dbc202bd6db4fb5c8b2abd1200e074a2a9e63a59 | |
| ToppCell | Bronchial-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.76e-05 | 159 | 105 | 5 | 7cda111bb98f1241989e49d490bdf51a712ea589 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 3.99e-05 | 161 | 105 | 5 | 64891f6f2ee1693c8481e951b9346e2f92d602e3 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Adult / Lineage, Cell type, age group and donor | 4.23e-05 | 163 | 105 | 5 | e819a1d6d28290854aa0672b3a18fa9e293d8f23 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D175|Adult / Lineage, Cell type, age group and donor | 4.75e-05 | 167 | 105 | 5 | c4e321bb87512ea839f324c92c0f1afea891483f | |
| ToppCell | Control-Epithelial_cells-Airway_basal|Control / group, cell type (main and fine annotations) | 5.31e-05 | 171 | 105 | 5 | 3965ced4be6db14265a90673502fceee425837ca | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 5.61e-05 | 173 | 105 | 5 | a5331721bd9f9a66530dd4ffe28cb3a5a8cad8fc | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic-Double_negative_thymocyte,_DN3_(Cd8-,_Cd4-),_some_express_pre_TCR_alpha|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.77e-05 | 174 | 105 | 5 | 0fccd90ef72ec2e5eb369fe6d6d126c60886485a | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.77e-05 | 174 | 105 | 5 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.77e-05 | 174 | 105 | 5 | 7fb7bdf62563f2102fb38618b503eb2817b6594f | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic-DN3_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.77e-05 | 174 | 105 | 5 | b2fc2a756f8e373ad903bd416d9de703d945fa1c | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.93e-05 | 175 | 105 | 5 | 06af6629766e2054e6995e8cdb3907658fec49d3 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.93e-05 | 175 | 105 | 5 | d52794426f2703a80e91ae0a8ff2d8e0ce4aa4a8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.93e-05 | 175 | 105 | 5 | 454f03e6109d65f5db08dbb41ecc19ffb6bbc4e0 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.09e-05 | 176 | 105 | 5 | a8875b4ba4abf6625cdeb67bf544ce1573c59060 | |
| ToppCell | COVID-19-Heart-CM_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.09e-05 | 176 | 105 | 5 | 9df7a124ebafb0087da0cda133a394275d7bed81 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l39|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.26e-05 | 177 | 105 | 5 | 928118b0ed120ec01c7d753ce523ab609ac24e5f | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.26e-05 | 177 | 105 | 5 | dbdbdc8ed9ef0b529694242ef9f9f07a42e16005 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.26e-05 | 177 | 105 | 5 | 88403b055eb9fdf96e4695fb6e0d78179e30a1e3 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.26e-05 | 177 | 105 | 5 | 8903aeaab61abd81a148ea623038c5114b8a183b | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.43e-05 | 178 | 105 | 5 | 416f85e51f45ec7949451fd47611a84e33e87245 | |
| ToppCell | COVID-19-kidney-vSMC/Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.60e-05 | 179 | 105 | 5 | 111b1084f73306bdeffaaf240e7dbb4f5bf33de1 | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_NK-T_NK-ILC_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.60e-05 | 179 | 105 | 5 | d18a520568cf4b031972d3dd7d4d4bd073ac1fea | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.60e-05 | 179 | 105 | 5 | 815b959ce8721c5ded70c0ca6e318dafc691746e | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_RPL31P31|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.60e-05 | 179 | 105 | 5 | d3d3a9afaac28fa4f2c448c73d79bcbbbea088d7 | |
| Drug | ML-9 | 4.78e-06 | 147 | 103 | 7 | CID000004217 | |
| Drug | S-(-)-Etomoxir | 6.25e-06 | 100 | 103 | 6 | CID000060765 | |
| Drug | AC1MRQNQ | 7.41e-06 | 9 | 103 | 3 | CID003522271 | |
| Drug | DHPASiU | 7.41e-06 | 9 | 103 | 3 | CID000197602 | |
| Drug | 3-iodophenol | 7.41e-06 | 9 | 103 | 3 | CID000012272 | |
| Drug | AC1L4J7U | 7.41e-06 | 9 | 103 | 3 | CID000186631 | |
| Drug | Chebi:32663 | 7.41e-06 | 9 | 103 | 3 | CID005460873 | |
| Drug | CARMINE | 7.44e-06 | 28 | 103 | 4 | CID000014749 | |
| Drug | Phosphatidylserine | 1.05e-05 | 10 | 103 | 3 | DB00144 | |
| Drug | AC1MU1S9 | NRG1 LDHAL6A MYH7B CHKB MYL12A PIKFYVE HPCA MYL9 CSF3 PIK3CA PRKCA MYL12B | 1.08e-05 | 572 | 103 | 12 | CID000003733 |
| Drug | M EG | 1.23e-05 | 66 | 103 | 5 | CID000004070 | |
| Drug | pregnenolone-16 alpha-carbonitrile | 1.33e-05 | 67 | 103 | 5 | CID000015032 | |
| Drug | 4-nitrophenyl)imidazole | 1.44e-05 | 11 | 103 | 3 | CID000123155 | |
| Drug | AC1O5XMV | 1.44e-05 | 11 | 103 | 3 | CID006442661 | |
| Drug | N-OH-DABZ | 1.92e-05 | 12 | 103 | 3 | CID000051366 | |
| Drug | 1-O-beta-D-glucopyranosyl-D-mannitol | 1.92e-05 | 12 | 103 | 3 | CID000088735 | |
| Drug | 2,4,6-TCB | 1.92e-05 | 12 | 103 | 3 | CID000037247 | |
| Drug | nonanoyl-N-methylglucamide | 1.92e-05 | 12 | 103 | 3 | CID000160090 | |
| Drug | 7,7,7-triphenylheptanoic acid | 1.92e-05 | 12 | 103 | 3 | CID000276709 | |
| Drug | AC1NSVQS | 1.92e-05 | 12 | 103 | 3 | CID005317517 | |
| Drug | AC1L8TMJ | 2.03e-05 | 2 | 103 | 2 | CID000407918 | |
| Drug | afloqualone | 2.03e-05 | 2 | 103 | 2 | ctd:C033541 | |
| Drug | iso-H7 | 2.33e-05 | 37 | 103 | 4 | CID000001352 | |
| Drug | tritanol | 2.49e-05 | 13 | 103 | 3 | CID000006457 | |
| Drug | 5-azido-UDP-glucuronic acid | 2.49e-05 | 13 | 103 | 3 | CID003081279 | |
| Drug | cotinine-N-glucuronide | 2.49e-05 | 13 | 103 | 3 | CID000000411 | |
| Drug | 12-deoxyphorbol 13-isobutyrate | 2.88e-05 | 39 | 103 | 4 | CID000107855 | |
| Drug | Pipenzolate bromide [125-51-9]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 3.10e-05 | 196 | 103 | 7 | 6821_UP | |
| Drug | propranolol glucuronide | 3.16e-05 | 14 | 103 | 3 | CID000119515 | |
| Drug | PCB-61 | 3.16e-05 | 14 | 103 | 3 | CID000036401 | |
| Drug | 6-Furfurylaminopurine [525-79-1]; Up 200; 18.6uM; MCF7; HT_HG-U133A | 3.21e-05 | 197 | 103 | 7 | 6813_UP | |
| Drug | buprenorphine hydrochloride solution | 3.52e-05 | 41 | 103 | 4 | CID000002476 | |
| Drug | AC1Q6O8B | 3.52e-05 | 41 | 103 | 4 | CID000000334 | |
| Drug | chelerythrine | CACNA1C LDHAL6A DGKG MYL12A PIKFYVE MYL9 PIK3CA PRKCA MYL12B | 3.56e-05 | 357 | 103 | 9 | CID000002703 |
| Drug | KT5926 | 3.87e-05 | 42 | 103 | 4 | CID000122126 | |
| Drug | fast white | 3.87e-05 | 42 | 103 | 4 | CID000024008 | |
| Drug | 2,2',3,5,5'-pentachlorobiphenyl | 3.93e-05 | 15 | 103 | 3 | CID000040469 | |
| Drug | afloqualone | 3.93e-05 | 15 | 103 | 3 | CID000002040 | |
| Drug | naphthyl sulphate | 3.93e-05 | 15 | 103 | 3 | CID000114775 | |
| Drug | coumarin-3-carboxylic acid | 3.93e-05 | 15 | 103 | 3 | CID000010752 | |
| Drug | sulforaphane nitrile | 3.93e-05 | 15 | 103 | 3 | CID000543743 | |
| Drug | quercetin-3,4'-diglucoside | 4.82e-05 | 16 | 103 | 3 | CID005320835 | |
| Drug | 1'-hydroxyestragole | 4.82e-05 | 16 | 103 | 3 | CID000040003 | |
| Drug | bilirubin-phosphate | 4.82e-05 | 16 | 103 | 3 | CID005497144 | |
| Drug | K-Cl | CACNA1C LDHAL6A FZD3 MYH7B DTNB CHKB YARS1 MYL12A MYL9 PRKCA MYL12B | 5.22e-05 | 567 | 103 | 11 | CID000004873 |
| Drug | 3 beta,5 alpha,25R)- 3-hydroxyspirostan-12-one | 5.84e-05 | 17 | 103 | 3 | CID000003573 | |
| Drug | 6-hydroxychrysene | 5.84e-05 | 17 | 103 | 3 | CID000037766 | |
| Drug | SureCN12722713 | 6.98e-05 | 18 | 103 | 3 | CID005488034 | |
| Drug | ethyl-beta-D-6-glucosiduronic acid | 6.98e-05 | 18 | 103 | 3 | CID000152226 | |
| Drug | Br 2 | 6.98e-05 | 18 | 103 | 3 | CID003060900 | |
| Drug | 2,3,7-trichlorodibenzo-p-dioxin | 6.98e-05 | 18 | 103 | 3 | CID000036614 | |
| Drug | ApApG | 6.98e-05 | 18 | 103 | 3 | CID003081975 | |
| Drug | C1 11-32 | 6.98e-05 | 18 | 103 | 3 | CID000443077 | |
| Drug | C11131 | 6.98e-05 | 18 | 103 | 3 | CID000443076 | |
| Drug | AC1L1JM9 | 7.31e-05 | 304 | 103 | 8 | CID000005103 | |
| Drug | 9-OH-risperidone | 8.27e-05 | 19 | 103 | 3 | CID000475100 | |
| Drug | 5alpha-spirostan-3beta-ol | 8.27e-05 | 19 | 103 | 3 | CID000091433 | |
| Drug | almokalant | 8.27e-05 | 19 | 103 | 3 | CID003033962 | |
| Drug | formycin triphosphate | 8.38e-05 | 51 | 103 | 4 | CID000122274 | |
| Drug | Finrazole | 8.38e-05 | 51 | 103 | 4 | CID000178036 | |
| Drug | 1 SA | 9.69e-05 | 20 | 103 | 3 | CID011987857 | |
| Drug | tectochrysin | 9.69e-05 | 20 | 103 | 3 | CID005281954 | |
| Drug | AC1L1OBF | 9.69e-05 | 20 | 103 | 3 | CID000032736 | |
| Drug | 4'-hydroxydiclofenac | 9.69e-05 | 20 | 103 | 3 | CID000116545 | |
| Drug | estriol-16-glucuronide | 1.13e-04 | 21 | 103 | 3 | CID000122281 | |
| Drug | dulcin | 1.13e-04 | 21 | 103 | 3 | CID000009013 | |
| Drug | Benzamidoxime hydrochloride | 1.13e-04 | 21 | 103 | 3 | CID000069186 | |
| Drug | trifluoperazine | 1.14e-04 | 324 | 103 | 8 | CID000005566 | |
| Drug | L-Tyrosine | 1.21e-04 | 4 | 103 | 2 | DB00135 | |
| Drug | AC1NS0D7 | 1.21e-04 | 4 | 103 | 2 | CID005326345 | |
| Drug | AC1L4TYZ | 1.21e-04 | 4 | 103 | 2 | CID000192227 | |
| Drug | ciprofibrate | 1.25e-04 | 170 | 103 | 6 | CID000002763 | |
| Drug | fluconazole | 1.27e-04 | 107 | 103 | 5 | CID000003365 | |
| Drug | amonafide | 1.30e-04 | 22 | 103 | 3 | CID000050515 | |
| Drug | N-methylpiperazine | 1.30e-04 | 22 | 103 | 3 | CID000053167 | |
| Drug | purealin | 1.39e-04 | 58 | 103 | 4 | CID006419303 | |
| Drug | SN-38G | 1.48e-04 | 59 | 103 | 4 | CID000443154 | |
| Drug | amidoxime | 1.49e-04 | 23 | 103 | 3 | CID000465967 | |
| Drug | estradiol-3-glucuronide | 1.49e-04 | 23 | 103 | 3 | CID000066651 | |
| Drug | phenanthridine | 1.49e-04 | 23 | 103 | 3 | CID000009189 | |
| Drug | erythromycin stearate | 1.51e-04 | 111 | 103 | 5 | CID000012559 | |
| Drug | aescine | 1.59e-04 | 60 | 103 | 4 | CID004555259 | |
| Drug | AC1L7AJI | 1.66e-04 | 256 | 103 | 7 | CID000003750 | |
| Drug | 3-OH | 1.69e-04 | 61 | 103 | 4 | CID000068152 | |
| Drug | AS-3201 | 1.70e-04 | 24 | 103 | 3 | CID000153948 | |
| Drug | alpha-CaM | 1.80e-04 | 62 | 103 | 4 | CID000196705 | |
| Drug | Y-27632 | 1.87e-04 | 444 | 103 | 9 | CID000005711 | |
| Drug | 5-MOP | 1.92e-04 | 25 | 103 | 3 | CID000002355 | |
| Drug | AzMC | 1.92e-04 | 25 | 103 | 3 | CID000064986 | |
| Drug | N-acetylbenzidine | 1.92e-04 | 25 | 103 | 3 | CID000018787 | |
| Drug | 5,6-benzoquinoline | 1.92e-04 | 25 | 103 | 3 | CID000006796 | |
| Drug | N-phenylmaleimide | 1.92e-04 | 25 | 103 | 3 | CID000013662 | |
| Drug | 1-phenyl-2-pyrrolidinone | 2.01e-04 | 5 | 103 | 2 | CID000078375 | |
| Drug | Dp-ba | 2.01e-04 | 5 | 103 | 2 | CID006440149 | |
| Drug | ethoxytriethyleneglycol | 2.30e-04 | 66 | 103 | 4 | CID000008190 | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 2.35e-04 | 191 | 103 | 6 | 7503_DN | |
| Drug | Farnesol | 2.43e-04 | 27 | 103 | 3 | ctd:D005204 | |
| Drug | diflunisal | 2.43e-04 | 27 | 103 | 3 | CID000003059 | |
| Drug | DiMeIQx | 2.43e-04 | 27 | 103 | 3 | CID000104739 | |
| Drug | Fillalbin [4540-25-4]; Up 200; 13.8uM; PC3; HT_HG-U133A | 2.55e-04 | 194 | 103 | 6 | 4092_UP | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 2.86e-07 | 17 | 100 | 4 | EFO_0004611, EFO_0007800 | |
| Disease | X-11793--oxidized bilirubin measurement | 2.09e-06 | 8 | 100 | 3 | EFO_0021260 | |
| Disease | Succinimide measurement | 2.09e-06 | 8 | 100 | 3 | EFO_0022118 | |
| Disease | X-11530 measurement | 2.09e-06 | 8 | 100 | 3 | EFO_0021249 | |
| Disease | sulfate of piperine metabolite C16H19NO3 (2) measurement | 2.09e-06 | 8 | 100 | 3 | EFO_0801034 | |
| Disease | cholelithiasis, bilirubin measurement | 2.09e-06 | 8 | 100 | 3 | EFO_0004570, EFO_0004799 | |
| Disease | X-11522 measurement | 2.09e-06 | 8 | 100 | 3 | EFO_0800696 | |
| Disease | X-10458 measurement | 2.09e-06 | 8 | 100 | 3 | EFO_0800692 | |
| Disease | X-24849 measurement | 2.09e-06 | 8 | 100 | 3 | EFO_0800909 | |
| Disease | membrane-associated progesterone receptor component 1 measurement | 2.09e-06 | 8 | 100 | 3 | EFO_0802740 | |
| Disease | X-16946 measurement | 2.09e-06 | 8 | 100 | 3 | EFO_0800766 | |
| Disease | X-11442 measurement | 3.13e-06 | 9 | 100 | 3 | EFO_0021236 | |
| Disease | X-11441 measurement | 3.13e-06 | 9 | 100 | 3 | EFO_0021235 | |
| Disease | circulating cell free DNA measurement | 3.13e-06 | 9 | 100 | 3 | EFO_0004739 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (3) measurement | 3.13e-06 | 9 | 100 | 3 | EFO_0801037 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (1) measurement | 3.13e-06 | 9 | 100 | 3 | EFO_0801036 | |
| Disease | X-11880 measurement | 3.13e-06 | 9 | 100 | 3 | EFO_0800698 | |
| Disease | protein-tyrosine kinase 6 measurement | 3.13e-06 | 9 | 100 | 3 | EFO_0020691 | |
| Disease | testis-specific chromodomain protein Y 1 measurement | 3.13e-06 | 9 | 100 | 3 | EFO_0802127 | |
| Disease | bilirubin measurement, response to xenobiotic stimulus | 3.13e-06 | 9 | 100 | 3 | EFO_0004570, GO_0009410 | |
| Disease | bilirubin measurement, response to tenofovir | 4.45e-06 | 10 | 100 | 3 | EFO_0004570, EFO_0009279 | |
| Disease | X-21448 measurement | 4.45e-06 | 10 | 100 | 3 | EFO_0800816 | |
| Disease | UDP-glucuronosyltransferase 1-6 measurement | 4.45e-06 | 10 | 100 | 3 | EFO_0802185 | |
| Disease | X-23974 measurement | 4.45e-06 | 10 | 100 | 3 | EFO_0800867 | |
| Disease | histidine betaine (hercynine) measurement | 6.11e-06 | 11 | 100 | 3 | EFO_0800972 | |
| Disease | X-21796 measurement | 6.11e-06 | 11 | 100 | 3 | EFO_0800825 | |
| Disease | insomnia, bilirubin measurement | 6.11e-06 | 11 | 100 | 3 | EFO_0004570, EFO_0004698 | |
| Disease | aldosterone measurement | 6.11e-06 | 11 | 100 | 3 | EFO_0010219 | |
| Disease | p-cresol glucuronide measurement | 8.13e-06 | 12 | 100 | 3 | EFO_0800079 | |
| Disease | biliverdin measurement | 8.13e-06 | 12 | 100 | 3 | EFO_0021033 | |
| Disease | retinol dehydrogenase 16 measurement | 1.05e-05 | 13 | 100 | 3 | EFO_0802007 | |
| Disease | Adenoid Cystic Carcinoma | 2.36e-05 | 100 | 100 | 5 | C0010606 | |
| Disease | blood urea nitrogen measurement | 2.38e-05 | 452 | 100 | 9 | EFO_0004741 | |
| Disease | angiopoietin-related protein 1 measurement | 2.97e-05 | 18 | 100 | 3 | EFO_0801382 | |
| Disease | ovarian cancer (is_implicated_in) | 3.98e-05 | 56 | 100 | 4 | DOID:2394 (is_implicated_in) | |
| Disease | free androgen index | 4.17e-05 | 374 | 100 | 8 | EFO_0007005 | |
| Disease | red blood cell density measurement | CACNA1C NRG1 NYAP2 ERG ACADS DNAH10 MECOM ARID1B PNPLA1 PIK3CA AKAP13 PRKAG2 | 4.35e-05 | 880 | 100 | 12 | EFO_0007978 |
| Disease | tissue factor measurement | 4.81e-05 | 21 | 100 | 3 | EFO_0010623 | |
| Disease | Acute Myeloid Leukemia, M1 | 6.87e-05 | 125 | 100 | 5 | C0026998 | |
| Disease | Acute Myeloid Leukemia (AML-M2) | 6.87e-05 | 125 | 100 | 5 | C1879321 | |
| Disease | Malignant neoplasm of breast | AKAP6 KDM3A NRG1 DGKG MECOM ARID1A CUL5 ARID1B SULF2 MIA2 CSF3 PIK3CA LRRC7 | 6.94e-05 | 1074 | 100 | 13 | C0006142 |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 1.13e-04 | 5 | 100 | 2 | C3281201 | |
| Disease | ovarian carcinoma | 1.14e-04 | 321 | 100 | 7 | EFO_0001075 | |
| Disease | xanthurenate measurement | 1.29e-04 | 29 | 100 | 3 | EFO_0010551 | |
| Disease | response to dolutegravir | 1.43e-04 | 30 | 100 | 3 | EFO_0600017 | |
| Disease | Hirschsprung Disease | 1.58e-04 | 31 | 100 | 3 | C0019569 | |
| Disease | Neoplasms, Therapy-Associated | 1.69e-04 | 6 | 100 | 2 | C0086696 | |
| Disease | Neoplasms, Second Primary | 1.69e-04 | 6 | 100 | 2 | C0085183 | |
| Disease | Treatment related secondary malignancy | 1.69e-04 | 6 | 100 | 2 | C0877578 | |
| Disease | thyroxine measurement | 1.86e-04 | 83 | 100 | 4 | EFO_0005130 | |
| Disease | Schizophrenia | CACNA1C NRG1 FZD3 UGT1A3 CTCF PIK3CA NCAN PRKCA CTNNA2 MAGEC1 HDAC1 | 2.03e-04 | 883 | 100 | 11 | C0036341 |
| Disease | differentiated thyroid carcinoma | 2.28e-04 | 35 | 100 | 3 | EFO_1002017 | |
| Disease | reticulocyte measurement | NYAP2 ACADS DNAH10 DTNB ACTR10 KLF3 FAF1 PPP1R2 CUL5 PIKFYVE PIK3CA AKAP13 | 2.35e-04 | 1053 | 100 | 12 | EFO_0010700 |
| Disease | Leukemia, Myelocytic, Acute | 3.14e-04 | 173 | 100 | 5 | C0023467 | |
| Disease | Lymphoid leukemia | 3.14e-04 | 8 | 100 | 2 | C0023448 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 3.67e-04 | 41 | 100 | 3 | C0496956 | |
| Disease | Breast adenocarcinoma | 3.67e-04 | 41 | 100 | 3 | C0858252 | |
| Disease | Carcinoma, Transitional Cell | 3.67e-04 | 41 | 100 | 3 | C0007138 | |
| Disease | progression free survival, response to carboplatin, methylcobalamin deficiency type cblE, ovarian serous carcinoma | 3.94e-04 | 42 | 100 | 3 | EFO_0004920, EFO_1001516, GO_0097328, MONDO_0009354 | |
| Disease | diastolic blood pressure, systolic blood pressure | 4.61e-04 | 670 | 100 | 9 | EFO_0006335, EFO_0006336 | |
| Disease | neuroblastoma (is_implicated_in) | 5.03e-04 | 10 | 100 | 2 | DOID:769 (is_implicated_in) | |
| Disease | QRS duration | 5.43e-04 | 298 | 100 | 6 | EFO_0005055 | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 6.08e-04 | 200 | 100 | 5 | EFO_0004611, EFO_0020945 | |
| Disease | pregnenetriol sulfate measurement | 6.13e-04 | 11 | 100 | 2 | EFO_0800586 | |
| Disease | plasma N-desmethylclozapine measurement | 6.13e-04 | 11 | 100 | 2 | EFO_0600039 | |
| Disease | cortical surface area measurement | FNIP2 PRTG NYAP2 FZD3 PPFIA1 MECOM DAPK1 FAF1 FBXO16 ARID1B SULF2 MAST4 PRKAG2 | 6.16e-04 | 1345 | 100 | 13 | EFO_0010736 |
| Disease | sleep quality | 7.09e-04 | 118 | 100 | 4 | EFO_0005272 | |
| Disease | non-high density lipoprotein cholesterol measurement | 7.19e-04 | 713 | 100 | 9 | EFO_0005689 | |
| Disease | middle cerebral artery infarction (is_implicated_in) | 7.34e-04 | 12 | 100 | 2 | DOID:3525 (is_implicated_in) | |
| Disease | Intestinal Neoplasms | 7.34e-04 | 12 | 100 | 2 | C0021841 | |
| Disease | Intestinal Cancer | 7.34e-04 | 12 | 100 | 2 | C0346627 | |
| Disease | phospholipid measurement, high density lipoprotein cholesterol measurement | 8.00e-04 | 321 | 100 | 6 | EFO_0004612, EFO_0004639 | |
| Disease | Coffin-Siris syndrome | 8.66e-04 | 13 | 100 | 2 | C0265338 | |
| Disease | pregnenetriol disulfate measurement | 8.66e-04 | 13 | 100 | 2 | EFO_0800587 | |
| Disease | triglycerides in medium VLDL measurement | 8.72e-04 | 55 | 100 | 3 | EFO_0022155 | |
| Disease | cardiac troponin T measurement | 9.14e-04 | 219 | 100 | 5 | EFO_0005043 | |
| Disease | triglycerides in large VLDL measurement | 9.19e-04 | 56 | 100 | 3 | EFO_0022178 | |
| Disease | lipid measurement, high density lipoprotein cholesterol measurement | 9.23e-04 | 330 | 100 | 6 | EFO_0004529, EFO_0004612 | |
| Disease | Adenocarcinoma Of Esophagus | 1.01e-03 | 14 | 100 | 2 | C0279628 | |
| Disease | urate measurement, spine bone mineral density | 1.02e-03 | 58 | 100 | 3 | EFO_0004531, EFO_0007701 | |
| Disease | body weight | AKAP6 CACNA1C NRG1 NCALD NEXMIF GON4L DGKG MECOM MAST4 ASXL3 CTNNA3 CTNNA2 | 1.15e-03 | 1261 | 100 | 12 | EFO_0004338 |
| Disease | BMI-adjusted adiponectin measurement | 1.16e-03 | 15 | 100 | 2 | EFO_0007737 | |
| Disease | triglycerides in small VLDL measurement | 1.18e-03 | 61 | 100 | 3 | EFO_0022145 | |
| Disease | free cholesterol in very large VLDL measurement | 1.18e-03 | 61 | 100 | 3 | EFO_0022274 | |
| Disease | response to bronchodilator, FEV/FEC ratio | 1.19e-03 | 766 | 100 | 9 | EFO_0004713, GO_0097366 | |
| Disease | phospholipids in large VLDL measurement | 1.24e-03 | 62 | 100 | 3 | EFO_0022169 | |
| Disease | total lipids in very large VLDL measurement | 1.24e-03 | 62 | 100 | 3 | EFO_0022313 | |
| Disease | phospholipids in very large VLDL measurement | 1.24e-03 | 62 | 100 | 3 | EFO_0022299 | |
| Disease | T-Cell Lymphoma | 1.32e-03 | 16 | 100 | 2 | C0079772 | |
| Disease | body mass index, type 2 diabetes mellitus | 1.32e-03 | 16 | 100 | 2 | EFO_0004340, MONDO_0005148 | |
| Disease | aspartate aminotransferase to alanine aminotransferase ratio | 1.35e-03 | 239 | 100 | 5 | EFO_0010934 | |
| Disease | cortical thickness | AKAP6 FNIP2 PRTG NYAP2 FZD3 MECOM FAF1 ARID1B SULF2 MAST4 PRKAG2 | 1.38e-03 | 1113 | 100 | 11 | EFO_0004840 |
| Disease | cholesterol in large VLDL measurement | 1.42e-03 | 65 | 100 | 3 | EFO_0021902 | |
| Disease | cholesterol in very large VLDL measurement | 1.42e-03 | 65 | 100 | 3 | EFO_0022230 | |
| Disease | X-21441 measurement | 1.50e-03 | 17 | 100 | 2 | EFO_0800814 | |
| Disease | total lipids in large VLDL | 1.55e-03 | 67 | 100 | 3 | EFO_0022175 | |
| Disease | MYELODYSPLASTIC SYNDROME | 1.55e-03 | 67 | 100 | 3 | C3463824 | |
| Disease | melanoma | 1.59e-03 | 248 | 100 | 5 | C0025202 | |
| Disease | triglycerides to phosphoglycerides ratio | 1.61e-03 | 68 | 100 | 3 | EFO_0022327 | |
| Disease | free cholesterol in large VLDL measurement | 1.61e-03 | 68 | 100 | 3 | EFO_0022265 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ESICNGVPMVMMPLF | 381 | P35503 | |
| LSSDEEMKMAEMRPP | 601 | Q96RT1 | |
| RSMMFEPGLTKGMLE | 761 | P53355 | |
| FMSDMPKPAFMKQNL | 411 | Q9UGJ0 | |
| MFSLMDKVPNGIEPM | 296 | Q93034 | |
| APNGDLTPEMILSMM | 711 | P49711 | |
| SFNMPSLDKMDGSMP | 611 | Q96RT6 | |
| EPGMGFKIAMQTLDM | 256 | P16219 | |
| SMPGNKAQEPEMMHD | 426 | Q9NP70 | |
| SYMEEKHMPPPNMTT | 106 | P11308 | |
| SLMPLMMTAQDPSSA | 296 | Q12802 | |
| KGLFLISMGMTDPEM | 2296 | Q12802 | |
| SQGSPMDPMVMKRPQ | 596 | Q8NFD5 | |
| MAQFHGMEMPFTKEP | 171 | Q9Y259 | |
| MMAEFPLDPQLAKMV | 561 | O43143 | |
| APKMEMSQAPSSVMS | 746 | A6H8M9 | |
| MKNPMASLMLPESEG | 186 | Q8IUH2 | |
| EMMFDVGKTQPPLMK | 396 | Q9NZ32 | |
| AIPMAPDMSGEAAML | 1031 | Q9Y2Q0 | |
| LANMLSPNMPMKEGD | 1986 | Q9C0F0 | |
| AMMNEAPGPINFTMF | 71 | P19105 | |
| METLEDAPDPFFGMM | 126 | O95072 | |
| MVSSVMKMPEDESTP | 131 | P84074 | |
| TPSGFFMEMMSMKPA | 21 | Q96RI1 | |
| VSMPSMAVSPFMEEE | 461 | Q02297 | |
| PGTPAMDKTSMVNMS | 446 | Q03112 | |
| RTPQPSSPMDQMGKM | 376 | O14497 | |
| PMEMEMLSLFSIPEN | 261 | Q9H2P9 | |
| FPMAMVCGNTFLMKP | 196 | Q02252 | |
| NFPAMTESGGMILAM | 4081 | Q8WXI7 | |
| MLMFDPVPVKQEAMD | 1 | P57682 | |
| MGDKDMPTAGMPSLL | 1 | O60732 | |
| AMMTQPQPSGAPMAK | 266 | Q9UJ55 | |
| MDPYMIQMSSKGNLP | 1 | P17735 | |
| FKPVMSKVMEMFQPS | 241 | Q13547 | |
| PDKMLGPEHGMSSMS | 981 | Q96NW7 | |
| EPTPQTSVQFMDKMM | 1816 | Q5CZC0 | |
| NPPRFDLLEDMAMMT | 121 | A7E2Y1 | |
| EGMMSEAPGPINFTM | 71 | P24844 | |
| NMMMVGVHGPKTPCE | 2666 | Q14315 | |
| MVSSVMKMPEDESTP | 131 | P37235 | |
| FLGPLSPSCKMVQMM | 86 | Q8N8W4 | |
| MMCEVMPTISEAEGP | 1 | Q13136 | |
| SSPSMQPKKMQMDGN | 1171 | Q13136 | |
| APMLGPENTMMSFEK | 206 | Q6W3E5 | |
| GLPKDMMVMLPQSDA | 161 | Q6UWW0 | |
| MISSKMMSSNPEEDP | 1 | Q9P242 | |
| MMVKSPSAPMAGEPV | 786 | Q9Y5F7 | |
| MKIDEPSTPYHSMMG | 66 | P41236 | |
| LFSMMLGSGMPELQS | 1001 | P42336 | |
| HDTFPFQKPMMETQM | 436 | O75694 | |
| ESLMPMIMPNSFIDA | 1016 | Q2VWP7 | |
| MPLEMEPKMSKLAFG | 1 | Q96MT3 | |
| SMNNSFTPAPMIMEI | 1706 | Q92794 | |
| IMMEMTDFTRGKGPL | 711 | Q9UI47 | |
| NQAPMMMGPPQKSSF | 766 | P49619 | |
| SFLMDEFAMPPTLMQ | 871 | Q9Y2I7 | |
| DMMPSRFDDLMANIP | 1056 | Q9Y4C1 | |
| MDEEKPRNMSMPTSE | 456 | Q13936 | |
| IMMEMTDFTRGKGPL | 721 | P26232 | |
| PASDVNMLGEMMFGS | 131 | Q9P278 | |
| AISETEDMPMFEPKM | 311 | Q3T8J9 | |
| AKQMGLFMEFGPEDM | 21 | Q5T0F9 | |
| LNMFLDTMMADPPPQ | 206 | O60941 | |
| ATLMKNMGPLPVDMA | 656 | O15021 | |
| MAGPATQSPMKLMAL | 1 | P09919 | |
| SKLMEMFGVPWPEDM | 111 | Q9NPG1 | |
| PAMGMFNTSMGKLQR | 16 | Q8NEG0 | |
| GMASSALRKSPMMPE | 311 | Q9UNN5 | |
| MMAFAPPKNTDGPKM | 1 | Q8IX29 | |
| MAGGPPNTKAEMEMS | 1 | Q969F0 | |
| PFRDVPKQMMQMFGL | 176 | Q8N0W7 | |
| PPMGKRLLVFMDDMN | 2511 | Q8IVF4 | |
| SVTAPMGITMKPAEM | 531 | Q7Z3Z3 | |
| MGKVKATPMTPEQAM | 146 | Q92630 | |
| MVSSVMKMPEDESTP | 131 | P61601 | |
| FENMPAAFMGMLKGD | 306 | Q14914 | |
| FNMPSLDKMDGSMPS | 1251 | Q96PC5 | |
| DAMMNEAPGPINFTM | 71 | O14950 | |
| MTSPVFDTMSAPLMG | 66 | Q8NET4 | |
| LMRAQDPGVMPASLM | 696 | Q8NET4 | |
| TASGMMSSMPQVKAP | 826 | Q8NET4 | |
| MSSMPQVKAPISGAM | 831 | Q8NET4 | |
| PMGASVPSIDSMMRK | 776 | Q6WKZ4 | |
| MNPMVPGLTGSKMSS | 211 | P54577 | |
| MGSLSFGVSELMKMP | 256 | P17252 | |
| CIQHGGPMASMKMPS | 1261 | Q5QGS0 | |
| GPMASMKMPSQKGLS | 1266 | Q5QGS0 | |
| AFPVATSPDLPMMAM | 621 | O14594 | |
| KSVDMIMDMFCPPGI | 581 | Q9NUX5 | |
| PNPKMPNTFMAVAMD | 351 | Q9HAT2 | |
| GPVDPMMADAIDFMV | 171 | Q9NZD8 | |
| RDVMGTKAFPGMLPM | 281 | Q9UPG8 | |
| LDPMATDASPMAINM | 16 | Q13023 | |
| PKMEADMSIPSMQGD | 4491 | Q8IVF2 | |
| MEMLPDTTGKGALMF | 481 | Q9UMS6 | |
| GFGEQKFMEDMMPKV | 146 | Q2QD12 | |
| PARDMQPTMKFVMDT | 431 | Q8IZW8 | |
| MKIDEPSPPYHSMMG | 66 | Q6NXS1 | |
| HMPSLPEMMFGDNVL | 41 | O75663 | |
| QAEGMEFGFKMPKMT | 791 | Q9BXM0 | |
| ESICNGVPMVMMPLF | 381 | P35504 | |
| PMMCQEMVPLGDSNS | 446 | A0A0J9YWL9 | |
| MKPGHLMGDPSAMVS | 251 | O00534 | |
| LPALDPMSMLFKMSN | 741 | Q63HK5 | |
| MPFTMPEAFLDDGDM | 266 | Q8IWR0 | |
| DDPFQMKTGGMVDMK | 66 | Q9NZ63 | |
| MTTSPMFMEKVSLEP | 201 | A5PLN9 | |
| GPMKPIHMEFTNMLQ | 266 | Q8IWU5 | |
| ESICNGVPMVMMPLF | 381 | P22310 | |
| ETMDLQHGSPFMKMP | 61 | Q6ZMR3 |